Vaccination and Immunization

Latest News



Primary care practices are the backbone of childhood immunization delivery, and have become indispensable in the promotion of public health. Over the last decades, however, the skyrocketing costs of vaccines have gone from a minor consideration in the overhead of a pediatric practice to one of significant financial burden, largely because of new vaccines.

Despite controversy surrounding the human papillomavirus (HPV) vaccine, more adolescents and young adults are getting vaccinated. However, overall vaccination rates of HPV compared with other teenaged-years vaccines are still low, says the Centers for Disease Control and Prevention (CDC).

Among concerns with administering these multiple and frequent immunizations in young children are the potential pain and adverse effects associated with injections. Along with inducing pain in some children, the early negative experience of needle-related procedures can interfere with adherence to immunization schedules and create long-lasting effects of anxiety and stress around needle-related procedures that remain into adulthood.

To reduce human papillomavirus (HPV)-related cancers, pediatricians must strongly recommend the underutilized HPV vaccine in preteens.

Recent data has revealed the live attenuated influenza vaccine (LAIV), also known as the “nasal spray” vaccine, to be grossly ineffective, leading to the ACIP’s decision not to recommend its usage. As such, healthcare providers must be judicious in their choice of influenza vaccine with their patients.

Maintaining the currently recommended vaccination schedule of influenza, pneumococcal conjugate, and diphtheria/tetanus/acellular pertussis vaccines in young children as put forth by the Centers for Disease Control and Prevention is likely the best way to manage immunization in this patient population despite the slightly increased risk for febrile seizure.